Physician profile

Jennifer L Ash

Vascular Surgery · Champaign, IL

NPI 1578761334

$8,875.69

in general payments reported to CMS, 2019-2025

25 companies · none reported in 2025

See the full distribution for Vascular Surgery

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Endologix LLC $5,627.73 2019-2022
Janssen Pharmaceuticals, INC $775.99 2019-2022
Medtronic, INC. $711.73 2021-2022
Medtronic Vascular, INC. $658.02 2019-2020
Cardiovascular Systems INC. $217.88 2019-2020
Pfizer INC. $152.63 2020-2022
Smith+Nephew, INC. $100.87 2019-2021
Osiris Therapeutics INC. $89.95 2019
Bard Peripheral Vascular, INC. $77.95 2019-2020
Philips North America LLC $53.00 2019-2020
Boston Scientific Corporation $47.27 2019-2020
Lemaitre Vascular, INC. $44.72 2019
Kci USA, INC. $37.67 2020
Organogenesis INC. $35.83 2019-2021
Melinta Therapeutics, LLC $34.69 2019
Show all 25 companies
CompanyGeneral paymentsYearsTop products
Cook Medical LLC $32.61 2019
Biotronik INC. $30.01 2021
Avinger INC. $24.22 2019
Misonix INC $22.44 2019
Aroa Biosurgery Incorporated $21.67 2020
Kerecis Limited $20.64 2022
Amgen INC. $16.84 2019
Terumo Medical Corporation $15.81 2020
Cardiva Medical, INC. $13.77 2020
E.R. Squibb & Sons, L.L.C. $11.75 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jennifer L Ash

$8,875.69

in general payments reported 2019-2025

Years
2019-2022
Top company
Endologix LLC

https://glasscript.com/doctor/162672/jennifer-l-ash

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.